Addex Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.03.22	Press Release: Addex Reports Full Year 2021 -2- (Dow Jones)
09.03.22	Ausblick: Addex Therapeutics gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
06.01.22	Press Release: Addex to Present at the H.C. Wainwright BIOCONNECT Virtual Conference (Dow Jones)
17.12.21	Press Release: Addex Raises $10.0 Million in Equity Financing (Dow Jones)
15.12.21	Press Release: Addex Provides Year End Pipeline Development Update (Dow Jones)
15.11.21	Press Release: Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149 (Dow Jones)
04.11.21	Press Release: Addex Reports Q3 2021 Financial Results and Provides Corporate Update (Dow Jones)
03.11.21	Ausblick: Addex Therapeutics stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
17.10.21	Erste Schätzungen: Addex Therapeutics zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
29.09.21	Press Release: Addex to Present at the Cantor Global Healthcare 2021 Conference (Dow Jones)
02.09.21	Press Release: Addex to Present at the Swiss Biotech Day (Dow Jones)
05.08.21	Press Release: Addex Reports 2021 Half Year and -2- (Dow Jones)
05.08.21	Press Release: Addex Reports 2021 Half Year and Second Quarter Financial Results and Provides Corporate Update (Dow Jones)
03.08.21	Ausblick: Addex Therapeutics verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net)
02.08.21	Press Release: Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of Translational Science (Dow Jones)
31.07.21	Ausblick: Addex Therapeutics legt Zahlen zum jüngsten Quartal vor (finanzen.net)
29.07.21	Press Release: Addex and Indivior Extend Research Collaboration on GABAB Positive Allosteric Modulators - Indivior Commits $4 Million of New Funding (Dow Jones)
18.07.21	Erste Schätzungen: Addex Therapeutics öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
07.07.21	Press Release: Addex Therapeutics to Present at Access to Giving Virtual Conference on July 14, 2021 (Dow Jones)
30.06.21	Press Release: Addex Establishes At-The-Market ADS Equity Sale Program (Dow Jones)
29.06.21	Press Release: Addex Therapeutics Initiates Pivotal Phase 2b/3 Study with Dipraglurant for Dyskinesia Associated with Parkinson's Disease (Dow Jones)
07.06.21	Press Release: Addex Starts Phase 2 Clinical Study of ADX71149 for Epilepsy (Dow Jones)
17.05.21	Press Release: Addex's Dipraglurant Restores Synaptic Plasticity in Models of Dystonia (Dow Jones)
05.05.21	Aktien Schweiz auf Erholungskurs (Dow Jones)
05.05.21	Press Release: Addex Reports Q1 2021 Financial -2- (Dow Jones)
04.05.21	Ausblick: Addex Therapeutics legt Quartalsergebnis vor (finanzen.net)
01.05.21	Ausblick: Addex Therapeutics gewährt Anlegern Blick in die Bücher (finanzen.net)
08.04.21	Press Release: Addex Files Registration Statement on Form F-3 with the US Securities and Exchange Commission (Dow Jones)
11.03.21	Press Release: Addex Reports Full Year 2020 -2- (Dow Jones)
11.03.21	Press Release: Addex Reports Full Year 2020 Financial Results and Provides Corporate Update (Dow Jones)
04.03.21	Press Release: Addex to Present at the H.C. Wainwright Global Life Sciences Conference (Dow Jones)
17.02.21	Press Release: Addex Provides Trading Update and Completes 2020 with Strong Cash Position of CHF18.7 million (Dow Jones)
16.02.21	Press Release: Addex GABAB Positive Allosteric Modulator Demonstrates Promise in Alcohol Use Disorder (Dow Jones)
21.01.21	Aktien Schweiz drehen nach Spung über die 11.000er Marke ins Minus (Dow Jones)
21.01.21	Stock Alert: Addex Therapeutics Soars 40% (RTTNews)
21.01.21	Pre-market Movers In Healthcare Sector: ADXN, CLSN, CLBS, JAGX, ECOR, ADMP… (RTTNews)
21.01.21	Press Release: Addex ADX71149 Receives IND Approval to Start a Phase 2a Clinical Study in Epilepsy (Dow Jones)
08.01.21	ALDX Catches Eye, RVNC Faces Busy Year Ahead, SRPT Plunges On DMD Trial Data (RTTNews)
07.01.21	Pre-market Movers In Healthcare Sector: GHSI, NMTR, NXTD, ADXN, DBVT… (RTTNews)
07.01.21	Press Release: Addex Announces Pricing of $10.0 Million Global Offering (Dow Jones)
14.12.20	Press Release: Addex Announces Filing of Registration Statement for Proposed Public Offering of Securities (Dow Jones)
03.11.20	Press Release: Addex Reports Q3 2020 Financial -2- (Dow Jones)
03.11.20	Press Release: Addex Reports Q3 2020 Financial Results and Provides Corporate Update (Dow Jones)
02.11.20	Press Release: Addex Receives Additional $2.8 million from Indivior and Extends GABAB PAM Research Collaboration (Dow Jones)
23.09.20	Press Release: Addex to Present at the Investora Conference (Dow Jones)
31.08.20	Press Release: Addex Therapeutics to Participate at the Biotechgate Digital Partnering Conference (Dow Jones)
27.08.20	Press Release: Addex and the SIB Swiss Institute of Bioinformatics Receive Innosuisse Grant to Repurpose Potent Dopamine Antagonist Using Computational Model... (Dow Jones)
12.08.20	Press Release: Addex Reports 2020 Half Year -2- (Dow Jones)
06.08.20	Press Release: Addex Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2020 (Dow Jones)
16.06.20	Press Release: Addex mGlu2 PAM Program to Advance into Epilepsy Phase 2a Proof of Concept Clinical Study (Dow Jones)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Addex Therapeutics Ltd (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten